This inventor holds 3 USPTO granted patents. Top assignee: Inhale Therapeutic Systems, Inc.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ako-gun, JP (2001)
- Hyogo, JP (2000 - 2002)
Company Filing History:
Years Active: 2000-2002
Title: Innovations by Shigenobu Kimura in Interferon Formulations
Introduction
Shigenobu Kimura, an inventive mind based in Hyogo, Japan, has made notable contributions to the field of pharmaceutical formulations. With a portfolio of three patents, his work primarily focuses on the development of dry powder compositions for interferons, particularly interferon-beta, enhancing therapeutic options for medical treatments.
Latest Patents
Kimura’s latest patents detail methods and compositions for spray-dried, interferon-based dry powder formulations. These compositions are designed to treat various conditions in humans that can benefit from interferon therapies. Through innovative spray drying techniques, Kimura has demonstrated the ability to produce stable, high-potency dry powder formulations of interferons, including but not limited to interferon-beta. Remarkably, this process allows for the preparation of interferon in high potency, making it particularly suitable for pulmonary delivery systems.
Career Highlights
Throughout his career, Shigenobu Kimura has collaborated with reputable organizations such as Inhale Therapeutics Systems, Inc. His involvement in these companies has significantly influenced the advancement of drug delivery technologies and the formulation of therapeutic agents.
Collaborations
In his journey, Kimura has worked alongside distinguished colleagues including Robert M. Platz and Yu-ichiro Satoh. These collaborations have fostered an environment of innovation and progress, contributing to the development of effective medical treatments using interferon-based formulations.
Conclusion
Shigenobu Kimura exemplifies the role of invention in the pharmaceutical industry, particularly through his pioneering work in interferon formulations. His methods for creating dry powder compositions not only enhance the stability and potency of these drugs but also open new avenues for treatment delivery, demonstrating the vital impact of innovations in addressing healthcare challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile